Navigation Links
Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group
Date:3/16/2011

SHANGHAI, March 16, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.  Shenogen Pharma Group is a China-based drug development venture that develops innovative therapeutics for the treatment of oncology indications including breast cancer and leukemia.

"We have evaluated multiple potential antibody development service partners in China," said Dr. Xueming Qian, who joined Shenogen as Vice President of Biology and Antibody Technology last June after working for twelve years in Amgen's discovery research group at its Thousand Oaks, California site.  "We decided to work with ChemPartner's Biologics Services team because they have the required therapeutic antibody drug research and development experience, expertise and people to support our therapeutic antibody program."

ChemPartner will be responsible for a spectrum of drug discovery activities for an integrated antibody drug development program including target protein production and cell line development, lead antibody generation and optimization (humanization and affinity maturation), assay development, protein analytics, DMPK, and in vivo pharmacology.

Dr. Chengbin Wu, Vice President of Biologics Services of ChemPartner, added, "We are delighted that Shenogen, an innovative drug development company, chose ChemPartner as its preferred outsource partner for antibody drug development.  Shenogen has a world-class management team and exclusive global intellectual property rights on a novel targ
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
2. American Scientific Resources Inc. Opens Shanghai Location
3. Shanghai ChemPartner Is Pleased to be Part of Agios Groundbreaking Cancer Research
4. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
5. China-Biotics to Host Investor Day in Shanghai to Discuss Corporate Development Strategy
6. Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification
7. Special Event Providing Exclusive Access to Shanghais Booming Zhangjiang Pharma Valley Added to Agenda of First Annual SBS China Conference
8. Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai
9. NSF International Opens NSF Shanghai Testing Laboratory in China to Support Increasing Demand for Testing and Certification Services
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... DRRX ) announced today financial results for the second ... loss was $5.5 million for the three months ended June ... and net loss of $5.5 million for the three months ... and investments of $37.8 million, compared to cash and investments ... 2015, we had $19.8 million in long term debt. ...
(Date:8/3/2015)... PARSIPPANY, N.J. , Aug. 3, 2015  LEO ... and Drug Administration (FDA) to include psoriasis as one ... Focused Drug Development Initiative i .  Psoriasis is an ... lives and subsequent comorbidities, affecting 7.5 million people in ... of LEO Pharma,s ongoing commitment to supporting patients living ...
(Date:8/3/2015)... N.Y. , Aug. 3, 2015 ... Wilmot Cancer Institute to the OmniSeq SM ... Roswell Park Cancer Institute (RPCI) and announced it ... that support a physician-driven, collaborative approach to genomic ... outcomes.  Wilmot Cancer Institute is a rapidly expanding, ...
Breaking Medicine Technology:DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 9DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 10LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 2LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 3OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3
... Researchers at Brigham and Women,s,Hospital found that patients taking ... effects were unrelated to relief from their pain,symptoms. ... examine the addictive,potential of this class of pain medicine, ... 25th Annual Meeting. , In ...
... Lethal ,Super, Strains of C.difficileCHICAGO, Jan. 28 ... scientists at The University of Nottingham are leading a ... one of the most lethal strains of hospital acquired ... technology developed in Nottingham to study the function of ...
Cached Medicine Technology:Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 3
(Date:8/4/2015)... ... August 04, 2015 , ... Patients are ... offered by the world renowned Beverly Hills facelift surgeon , Dr. Paul ... surgery techniques helps individuals to achieve an outer appearance that meets their personal ...
(Date:8/4/2015)... & LAS VEGAS (PRWEB) , ... August 04, 2015 , ... ... the pitch schedule for vendor participating in The ISE® Lions’ Den and Jungle Lounge ... Spa at Aria in Las Vegas. , During the event, eight emerging security vendors, ...
(Date:8/4/2015)... Las Vegas, Nevada (PRWEB) , ... August 04, ... ... INTIMATELY FEMALE, a striking contemporary look at unique artistic expressions from a diverse ... Motel inside the Life Is Beautiful Music & Art Festival on September 25-27, ...
(Date:8/4/2015)... ... 04, 2015 , ... Data2Life , a Tel Aviv-based ... provide pharmaceutical and healthcare organizations with advanced intelligence on drug effects. The product ... filings (including the FDA and HealthCanada), social media and anonymized clinical electronic health ...
(Date:8/4/2015)... ... 2015 , ... METTLER TOLEDO has announced an upcoming online ... Lubrizol, Pfizer, and Merck. This free online seminar will be held on ... require informed decisions with limited process understanding. Established methods have been developed ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2
... STANFORD, Calif. The immune system may play a critical ... therapies, according to a new study by researchers at the ... disable cancer-promoting genes called oncogenes are much more successful in ... by kind of immune cell called a T helper cell. ...
... improved planning of care and stronger relationships with physicians ... to a study by a Queen,s University professor. , ... every Canadian," says professor of Medicine and Epidemiology Daren ... Hospital. "But it,s not always happening. We know from ...
... (HealthDay News) -- Treatments designed to tackle childhood obesity ... education programs are as effective as those that enlist ... parent-only programs are also generally cheaper and more practical ... the parent-only group was not inferior in terms of ...
... Reporter , TUESDAY, Oct. 26 (HealthDay News) -- As ... prevented if people followed five simple healthy lifestyle recommendations, ... improve overall health as well -- include exercise, a ... healthy weight, the researchers say. "Even a modest ...
... to hormonal changes and inflammation has been awarded a ... study. The research programme at the National Institute ... led by Professor Julian Davis, a consultant endocrinologist at ... Manchester,s Developmental Biomedicine Research Group. He is working ...
... Wu has invented a portable scanner based on radio frequency technology, ... tumours malignant and benign in the breast on a ... detection has been proven by researchers in the US, Canada and ... for an image to be produced, and this had to be ...
Cached Medicine News:Health News:Certain cancer therapies' success depends on presence of immune cell, Stanford study shows in mice 2Health News:Certain cancer therapies' success depends on presence of immune cell, Stanford study shows in mice 3Health News:Certain cancer therapies' success depends on presence of immune cell, Stanford study shows in mice 4Health News:Parent-Only Programs Can Help Obese Kids Lose Weight: Study 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 3Health News:Manchester team wins $1.9 million grant for 'cell control' study 2Health News:Portable breast scanner allows cancer detection in the blink of an eye 2
... Designed specifically to ... interventionalists, Sequitor facilitates the ... the peripheral vasculature for ... both uterine fibroid embolization ...
Reference Lab Interface (RLI)© for SRS Software, provides real-time processing of HL7 lab data directly into SRS Freedom Chart ManagerTM, producing an HTML form in the patients chart/tab, whil...
... technology innovation, the new Guidant VASOVIEW® 7 ... the VASOVIEW® platform. The new VASOVIEW® 7 ... familiar platform, combining ease of use with ... finesse into a proven system. Discover advanced ...
Patient Monitor...
Medicine Products: